Sequent Scientific Ltd Financials
Company Logo

Sequent Scientific Ltd Financial Statement

Sequent Scientific Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue54.60
Operating Expense45.40
Net Profit4.23
Net Profit Margin7.75
Earning Per Share0.17
EBIDTA8.63
Effective Tax Rate12.07

Sequent Scientific Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual178.26
Operating Expenses Annual189.64
Operating Profit Annual34.67
Interest Annual3.96
Depreciation8.41
Net Profit Annual15.79
Tax Annual6.25

Sequent Scientific Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning0.93
Cash Flow from Operations-1.13
Cash Flow from Investing-0.44
Cash Flow from Financing0.67
Cash Flow at the End0.03

Sequent Scientific Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)19.45
PBIT Margin (%)14.59
PBT Margin (%)10.90
Net PROFIT Margin (%)8.86
Return On Networth / Equity (%)1.42
Return On Networth /Employed (%)2.23
Return On Assets (%)1.33
Total Debt / Equity (X)0.04
Asset Turnover Ratio (%)0.15

Sequent Scientific Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual46.40
Total Current Assets Annual107.53
Non Current Assets Annual1,114.68
Total Shareholders Funds Annual1,142.65
Total Assets Annual1,222.20

Sequent Scientific Ltd Earning Calls

EPS (INR)

Expected

0.37

Reported

0.37

Surprise

0.00%

Dec 2024

EPS beaten by 0.00%

Sep 2024

EPS beaten by 0.00%

Jun 2024

EPS beaten by 10.00%

FAQS on Sequent Scientific Ltd Financials

As of Jul 27, 2025, Sequent Scientific Ltd has a market capitalization of 3,273.95 Cr. Value Research classifies it as a Mid-Cap company.

Yes, Sequent Scientific Ltd is with a debt-to-equity ratio of 0.04.

In FY 2024 , Sequent Scientific Ltd recorded a total revenue of approximately 178.26 Cr marking a significant milestone in the company's financial performance.

Sequent Scientific Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and -0.1% annually, respectively..

Sequent Scientific Ltd's current PE ratio is 207.21.

Sequent Scientific Ltd's ROCE averaged 0.9% from the FY ending March 2023 to 2025, with a median of 0.9%. It peaked at 2.6% in March 2025, reflecting strong capital efficiency over the period..

Sequent Scientific Ltd's latest EBIT is Rs. 26.01 Cr, surpassing the average EBIT of Rs. 7.63 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions